CIBC Private Wealth Group
ITCI

CIBC Private Wealth Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

CIBC Private Wealth Group’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19
Closed -$1.57K – 3295
2024
Q4 		$1.57K Buy
+19
New +$1.56K ﹤0.01% 2736
2024
Q3 		– Sell
-25
Closed -$1.79K – 3323
2024
Q2 		$1.79K Sell
25
-9
-26% -$624 ﹤0.01% 2784
2024
Q1 		$2.32K Sell
34
-8,566
-100% -$589K ﹤0.01% 2719
2023
Q4 		$616K Hold
8,600
– – ﹤0.01% 746
2023
Q3 		$448K Buy
+8,600
New +$501K ﹤0.01% 781
2018
Q2 		– Sell
-10,200
Closed -$215K – 2116
2018
Q1 		$215K Buy
+10,200
New +$199K ﹤0.01% 920

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

CIBC Private Wealth Group's ITCI Position: Q1 2025 in Review

CIBC Private Wealth Group sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 19 shares — an estimated $1.57K sold.

CIBC Private Wealth Group first reported a position in ITCI in Q1 2018 and held it in 6 quarters. The position peaked at $616K in Q4 2023. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • CIBC Private Wealth Group reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • CIBC Private Wealth Group sold 19 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $1.57K.
  • CIBC Private Wealth Group first reported a position in Intra-Cellular Therapies Inc. in Q1 2018 and held it in 6 quarters.
  • CIBC Private Wealth Group's Intra-Cellular Therapies Inc. position peaked at $616K in Q4 2023.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on CIBC Private Wealth Group's 13F filing for Q1 2025, filed 14 May 2025.